Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details



SMi is delighted to announce the 13th annual ADMET conference returning to London on the 9th - 10th July 2018.

Add this event to your calendar: iCal   Google Calendar


Chaired by Eric Bloome, Vice President, Global Pre-Clinical Safety Senior Research Fellow, AbbVie

Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost, and minimise production times.
The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage.

Join our expert speaker panels at the ADMET conference to ensure you do not miss out on the latest developments!
Presenting new technologies, specific case studies and PK modelling strategies in the areas of DMPK, PBPK, PKPD, in vitro / ex vivo / in vivo / in silico, biologics, transporters, hazard and safety assessments, ADMET modelling, and many more.

This event is CPD accredited.

The ADMET conference will cover new developments in all areas of the ADMET sector, from the evaluation of novel PBPK modelling techniques to the validation of humanised mice models.

Join us this year in July to hear from our expert speaker panel, bringing you interesting case studies and detailed presentations on new and industry relevant topics, including:
ADME/PK Optimisation for Drug Design and Discovery 
Physiochemical Assessments
Drug Screening Technology 
In Vitro to Human In Vivo Translation 
DMPK, PBPK and PKPD Modelling
Pre-/Clinical Toxicity 
Accurate First-in-Human Dose Predictions 
Transporters, Bioavailability, Formulation 
Metabolism Studies
Drug-Drug Interactions


Conference Only GBP 1499 Distribution of your company’s promotional literature to all conference attendees GBP 999 Access to the conference documentation on the Document Portal GBP 499 The Conference Presentations – paper copy GBP 499


Simi Sapal

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.